Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial
Titel:
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial
Auteur:
Maggiolo, Franco Rizzardini, Giuliano Molina, Jean-Michel Pulido, Federico De Wit, Stephane Vandekerckhove, Linos Berenguer, Juan D’Antoni, Michelle L. Blair, Christiana Chuck, Susan K. Piontkowsky, David Martin, Hal Haubrich, Richard McNicholl, Ian R. Gallant, Joel